INS and Insulin resistance: We previously showed that the risk of developing diabetes in the ACT NOW Study was closely related to waning β cell function as determined by the insulin secretion/insulin resistance (IS/IR) index and that an improved IS/IR index with pioglitazone was the strongest predictor for reduced risk of conversion to diabetes.